Arteris, Inc. (NASDAQ:AIP) Short Interest Down 14.2% in November

Arteris, Inc. (NASDAQ:AIP) was the target of a significant decrease in short interest in the month of November. As of November 15th, there was short interest totalling 509,900 shares, a decrease of 14.2% from the October 31st total of 594,400 shares. Based on an average daily trading volume, of 106,900 shares, the short-interest ratio is presently 4.8 days. Approximately 2.0% of the company’s shares are short sold.

Wall Street Analysts Forecast Growth

Separately, Rosenblatt Securities reiterated a “buy” rating and issued a $15.00 target price on shares of Arteris in a report on Wednesday, November 6th.

Arteris Trading Up 2.1 %

NASDAQ AIP opened at $8.69 on Monday. Arteris has a one year low of $4.83 and a one year high of $9.54. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. The firm has a market cap of $349.16 million, a P/E ratio of -9.05 and a beta of 1.13. The stock’s 50-day moving average is $7.62 and its 200-day moving average is $7.74.

Insider Activity at Arteris

In other news, CFO Nicholas B. Hawkins sold 11,628 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $7.86, for a total value of $91,396.08. Following the completion of the sale, the chief financial officer now directly owns 224,659 shares of the company’s stock, valued at $1,765,819.74. This represents a 4.92 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO K Charles Janac sold 5,520 shares of the stock in a transaction that occurred on Wednesday, October 2nd. The shares were sold at an average price of $7.18, for a total transaction of $39,633.60. Following the completion of the sale, the chief executive officer now owns 287,247 shares in the company, valued at $2,062,433.46. This represents a 1.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 143,409 shares of company stock worth $1,059,138 over the last ninety days. Company insiders own 33.70% of the company’s stock.

Institutional Trading of Arteris

Large investors have recently bought and sold shares of the business. Vanguard Group Inc. increased its holdings in Arteris by 0.3% during the 1st quarter. Vanguard Group Inc. now owns 1,146,224 shares of the company’s stock worth $8,390,000 after purchasing an additional 3,242 shares in the last quarter. US Bancorp DE acquired a new position in shares of Arteris during the third quarter worth about $34,000. Renaissance Technologies LLC grew its holdings in shares of Arteris by 6.1% during the second quarter. Renaissance Technologies LLC now owns 114,700 shares of the company’s stock worth $861,000 after buying an additional 6,600 shares in the last quarter. MetLife Investment Management LLC raised its position in Arteris by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock valued at $131,000 after buying an additional 9,551 shares during the last quarter. Finally, The Manufacturers Life Insurance Company bought a new stake in Arteris in the 2nd quarter valued at approximately $86,000. 64.36% of the stock is owned by institutional investors.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.